Picture of Stayble Therapeutics AB logo

STABL Stayble Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Stayble Therapeutics Engages Ferghana To Support Partnering Activities

Oct 24 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * STAYBLE THERAPEUTICS ENGAGES FERGHANA PARTNERS TO SUPPORT
PARTNERING ACTIVITIES
    * TOPLINE RESULTS ARE EXPECTED TO BE PRESENTED IN NOVEMBER
OR
EARLY DECEMBER 2023
    * HAS ENTERED AGREEMENT WITH FERGHANA FOR UPCOMING CLINICAL
RESULTS FROM THE PHASE 2B STUDY STA363

Source text for Eikon:  ID:nWkr2M0d3G 
Further company coverage:  STABL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Stayble Therapeutics AB

See all news